HeartBeam Inc. to Unveil Q2 Financial Results and Advancements in Cardiac Care Technology

HeartBeam Inc. (NASDAQ: BEAT) has scheduled a conference call for August 13, 2025, at 4:30 p.m. Eastern Time, to discuss its second-quarter financial results ending June 30, 2025. The call, led by CEO Robert Eno and CFO Timothy Cruickshank, will also cover the company's regulatory initiatives, commercial-readiness activities, and key milestones. This event is not just about financial performance but also about HeartBeam's pioneering role in cardiac care technology.

The company is developing the first cable-free 12-lead ECG system, a technology that captures the heart's electrical signals in three dimensions. This innovation could revolutionize patient care by providing physicians with actionable cardiac data outside traditional medical settings, enabling early detection and intervention for heart conditions. With 13 U.S. and 4 international patents, HeartBeam's technology is a significant advancement in cardiac health management.

For those interested in the future of cardiac care technology, the conference call is a must-attend event. More information about HeartBeam's innovative solutions can be found at https://www.HeartBeam.com. Updates and news regarding BEAT are available through the company's newsroom at https://ibn.fm/BEAT.

This announcement highlights HeartBeam's dedication to advancing cardiac care technology and its potential to significantly impact healthcare delivery. The upcoming conference call will offer insights into the company's direction and its contribution to the future of heart health management.